The results showed that downregulated CTLA4 expression was associated with worse OS in the Swedish dataset of metastatic melanoma patients (p = 0.0046) (Figure 1D), consistent with the observations in the TCGA dataset. The gene discussed is CTLA4; the disease is metastatic melanoma.